Back
XOMA Royalty Corp. 10K Form
Buy
53
XOMA
XOMA Royalty Corp.
Last Price:
$31.00
Seasonality Move:
10.9%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-09 | 10Q | XOMA/XOMA Royalty Corp. Quarterly |
| 2023-11-07 | 10Q | XOMA/XOMA Royalty Corp. Quarterly |
| 2023-08-08 | 10Q | XOMA/XOMA Royalty Corp. Quarterly |
| 2023-05-09 | 10Q | XOMA/XOMA Royalty Corp. Quarterly |
| 2022-11-03 | 10Q | XOMA/XOMA Royalty Corp. Quarterly |
| 2022-08-04 | 10Q | XOMA/XOMA Royalty Corp. Quarterly |
Receive XOMA News And Ratings
See the #1 stock for the next 7 days that we like better than XOMA
XOMA Financial Statistics
Sales & Book Value
| Annual Sales: | $28.5M |
|---|---|
| Cash Flow: | $-957K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $7.14 |
| Price / Book: | 4.37 |
Profitability
| EPS (TTM): | 0.74550 |
|---|---|
| Net Income (TTM): | $15.6M |
| Gross Margin: | $28.3M |
| Return on Equity: | 17.31% |
| Return on Assets: | 6.8% |
XOMA Royalty Corp. Earnings Forecast
Key XOMA Royalty Corp. Financial Ratios
-
The Gross Profit Margin over the past 41 years for XOMA is 99.24%.
-
The Selling, General & Administrative Expenses for XOMA have been equal to 121.03% of Gross Profit Margin.
-
The Research & Development expenses have been 10.09% of Revenue.
-
The Net Earning history of XOMA is -48.52% of Total Revenues.
-
Per Share Earnings over the last 41 years have been positive in 16 years.
XOMA Royalty Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | XOMA |
| CUSIP: | 98419J |
| Website: | xoma.com |
Debt
| Debt-to-Equity Ratio: | 1.22 |
|---|---|
| Current Ratio: | 3.91 |
| Quick Ratio: | 3.38 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
XOMA Technical Analysis vs Fundamental Analysis
Buy
53
XOMA Royalty Corp. (XOMA)
is a Buy
Is XOMA Royalty Corp. a Buy or a Sell?
-
XOMA Royalty Corp. stock is rated a BuyThe current XOMA Royalty Corp. [XOMA] share price is $31.00. The Score for XOMA is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.